[Diagnosis, biomarkers and biochemical alterations in Gaucher's disease].

Abstract

Gaucher's disease (GD) is an inherited metabolic disease due to lack of activity of the enzyme betaglucocerebrosidase. The diagnosis of GD is usually performed by fluorimetric analysis of the enzyme betaglucocerebrosidase. It can also be done by measuring the activity of tandem mass spectrometry. This enzyme can be analyzed in different samples such as leukocytes, fibroblasts, blood dried on paper and in case of prenatal diagnosis in chorionic villi or culture of amniocytes. Various biomarkers have been described for monitoring GD once diagnosed, to evaluate the response to potential treatments. Chitotriosidase activity is the most widely used biomarker for the assessment of GD, and for patients homozygous for the null CHIT1 gene variants, in general, is replaced by the analysis of the biomarker CCL18.

• Authors: Laura Gort, M José Coll
• Journal: Medicina clinica (Med Clin (Barc)) Vol. 137 Suppl 1 Pg. 12-6 (Sep 2011) ISSN: 1578-8989 [Electronic] Spain
• Vernacular Title: Diagnóstico, biomarcadores y alteraciones bioquímicasde la enfermedad de Gaucher.
• PMID: 22230120 (Publication Type: English Abstract, Journal Article)
• Copyright: Copyright © 2011 Elsevier España S.L. All rights reserved.

Chemical References

• Biomarkers
• CCL18 protein, human
• Chemokines, CC
• Hexosaminidases
• chitotriosidase
• Glucosylceramidase

Topics

• Biomarkers (analysis)
• Chemokines, CC (analysis)
• Fibroblasts (enzymology)
• Gaucher Disease (diagnosis, enzymology, genetics)
• Glucosylceramidase (analysis, genetics)
• Hexosaminidases (analysis, genetics)
• Humans
• Leukocytes (enzymology)